top of page

COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP

Product details

Registration number: SIN06281P

Classification: General Sale List

Active ingredients:

  • CALCIUM CHLORIDE
  • LACTIC ACID
  • POTASSIUM CHLORIDE
  • SODIUM CHLORIDE
  • SODIUM HYDROXIDE

Strength:

  • 0.027 g/100 ml
  • 0.24 ml/100 ml
  • 0.04 g/100 ml
  • 0.6 g/100 ml
  • 0.115 g/100 ml

Dosage form: INJECTION

Route: INTRAVENOUS

Registrant: LUEN WAH MEDICAL COMPANY (SINGAPORE) PRIVATE LIMITED

ATC code: B05XA31

HSA approval date: 11 June 1991

Manufacturer(s):

  • PT OTSUKA INDONESIA
  • THAI OTSUKA PHARMACEUTICAL CO LTD

Manufacturing country/countries: INDONESIA REP OF; THAILAND

What are the HSA registration number and classification for COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN06281P

Classification: General Sale List

Source for this answer

What active ingredients and strength are recorded for COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP?

According to the HSA dataset updated 7 August 2026:

Active ingredients:

  • CALCIUM CHLORIDE
  • LACTIC ACID
  • POTASSIUM CHLORIDE
  • SODIUM CHLORIDE
  • SODIUM HYDROXIDE

Strength:

  • 0.027 g/100 ml
  • 0.24 ml/100 ml
  • 0.04 g/100 ml
  • 0.6 g/100 ml
  • 0.115 g/100 ml

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION

Route: INTRAVENOUS

Source for this answer

Who is the recorded registrant for COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP?

According to the HSA dataset updated 7 August 2026:

Registrant: LUEN WAH MEDICAL COMPANY (SINGAPORE) PRIVATE LIMITED

Source for this answer

Which manufacturers and countries are listed for COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • PT OTSUKA INDONESIA
  • THAI OTSUKA PHARMACEUTICAL CO LTD

Manufacturing country/countries: INDONESIA REP OF; THAILAND

Source for this answer

Where can I look up COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN06281P or the exact product name COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP. The general register link does not preselect this product.

Source for this answer

What are the source dates for this COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN06281P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page